Xiaoyuan Xu
- Epidemiology top 5%
- Hepatology top 1%
- Molecular Biology
- Surgery
- Clinical Biochemistry top 5%
- Topics
- Liver Disease Diagnosis and Treatment (60 papers)Hepatitis C virus research (52 papers)Hepatitis B Virus Studies (52 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Xiaoyuan Xu
108 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 109
- Epidemiology 684
- Hepatology 619
- Molecular Biology 187
- Surgery 114
- Clinical Biochemistry 111
Countries citing papers authored by Xiaoyuan Xu
This map shows the geographic impact of Xiaoyuan Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyuan Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyuan Xu more than expected).
Fields of papers citing papers by Xiaoyuan Xu
This network shows the impact of papers produced by Xiaoyuan Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyuan Xu. The network helps show where Xiaoyuan Xu may publish in the future.
Co-authorship network of co-authors of Xiaoyuan Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyuan Xu. A scholar is included among the top collaborators of Xiaoyuan Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyuan Xu. Xiaoyuan Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 0 | |
| 6 | 0 | |
| 7 | 22 | |
| 8 | 13 | |
| 9 | 4 | |
| 10 | 0 | |
| 11 | Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022)breakdown → | 97 |
| 12 | 9 | |
| 13 | 2 | |
| 14 | 8 | |
| 15 | 3 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 38 | |
| 19 | Pharmacy Education Quality Assurance in China: Moving Towards a National Accreditation System? | 0 |
| 20 | [Plain radiograph and CT features of 112 patients with SARS in acute stage]. | 8 |
About Xiaoyuan Xu
Xiaoyuan Xu is a scholar working on Hepatology, Epidemiology and Pharmacology, having authored 124 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (60 papers), Hepatitis C virus research (52 papers) and Hepatitis B Virus Studies (52 papers). The work is most often cited by research in Hepatology (619 citations), Epidemiology (684 citations) and Clinical Biochemistry (111 citations). Xiaoyuan Xu has collaborated with scholars based in China, United States and France. Frequent co-authors include Hui Zhuang, Jidong Jia, Wengang Li, Lai Wei, Yuemin Nan, Zhongping Duan, Enqiang Linghu, Hong You, Huiguo Ding and Jinghang Xu. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.